Brief: Allena Pharmaceuticals Says On Dec 23, Co Entered Into Renewed, Replacement At Market Issuance Sales Agreement With B. Riley Securities Inc
Dec 23 (Reuters) - Allena Pharmaceuticals Inc ALNA.O :
* ALLENA PHARMACEUTICALS INC - ON DEC 23, CO ENTERED INTO
RENEWED,
REPLACEMENT AT MARKET ISSUANCE SALES AGREEMENT WITH B. RILEY
SECURITIES, INC.
* ALLENA PHARMACEUTICALS INC - CO MAY CONTINUE TO OFFER AND
SELL
SHARES AT OFFERING PRICE OF UP TO $50 MILLION
Source text for Eikon: ID:
Further company coverage: ALNA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Allena Pharmaceuticals
See all newsBrief: Allena Pharmaceuticals Inc - On September 6, Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On September 8, 2022
U.S. STOCKS ON THE MOVE-Relmada, Entera Bio, Eli Lilly
U.S. STOCKS ON THE MOVE-ChannelAdvisor, HyreCar, ADT, miners
U.S. STOCKS ON THE MOVE-Timken, Bed Bath & Beyond, HyreCar, chip stocks
Allena down on bankruptcy filing